CVI Peripheral Interventional Octagon - Extreme CLI and No-option Patients Webinar скачать в хорошем качестве

CVI Peripheral Interventional Octagon - Extreme CLI and No-option Patients Webinar

CVI's cased-based competitive learning webinar series - The Interventional Octagon - presents a Peripheral/Endovascular session feature cases submitted by fellows and early-career physicians. Finalists selected from submitted cases in the topic of "Extreme CLI and No-option Patients” receive a travel grant to CVI 2026 and compete for a prize ($500 Amazon Gift Card). Moderators:  Moderators: Mehdi Shishehbor, DO, MPH, PhD and Subhash Banerjee, MD Judging Panelists: John Eidt, MD Jun Li, MD, and Javier Vasquez, MD Finalists Hector Elizondo Adamchick, MD, Baylor Scott and White, Dallas, TX - An option for "no-option" CLTI patients: Deep Venous Arterialization Ekramul Gofer, MD, Miami Cardiac and Vascular Institute, Baptist Health - Persistent CLTI Despite Multiple Interventions Gordon Wong, MD, University Hospitals Harrington Heart and Vascular Institute, Cleveland, OH - Acute Limb Ischemia Involving Occlusion of a Stented Femoropopliteal Bypass Graft Ahmad Younes, MD, ProMedica, Toledo, OH - There Are Options! Learning Objectives: • Discuss technical aspect of retrograde digital and pedal access • Evaluate options for severely calcified arteries • Evaluate clinical approaches, managing complications and trouble-shooting techniques in deep venous arterialization • Recall post-op care, wound care, management and outcomes of the salvaged limb For full details on the Interventional Octagon webinar series, visit: https://cvinnovations.org/2024/12/04/... This activity has been approved for AMA PRA Category 1.25 Credit™. Claim CME Credit 1.  View the webinar 2. At the end of the webinar, log onto: https://www.online-med-edu.com/cvi/10... 3. Complete the Evaluation/Credit Request Form 4. Download or Print Credit Statement/Certificate Interventional Octagon is made possible by generous grants from Abbott, Boston Scientific Corporation, Cordis, and Medtronic.